Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
Yahoo28d
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
president of Lilly Cardiometabolic Health and Lilly USA, in a press release. The approval is based on a clinical trial from earlier this year, which showed Zepbound was five times more effective ...
Morningstar3d
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic response at one year Among those who achieved clinical ...
Yahoo Finance26d
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity," said Patrik Jonsson, president of Lilly USA.
Lilly Ledbetter, equal pay trailblazer who changed US law, dies at 86
The Lilly Ledbetter Fair Play Act plugged a loophole that foiled her wage discrimination claims against Goodyear and its Gadsden plant.
UPI28d
FDA approves weight-loss drug Zepbound to treat sleep apnea
president of Lilly Cardiometabolic Health and Lilly USA. "Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity.
Lilly Pulitzer gets rights to archive prints by artist credited with creating 'Lilly Look'
The deal will open the door for the company to tap into an archive of more than 2,000 designs by Key West Hand Print Fabrics Co. and Suzie Zuzek.
Stockhouse3d
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic response at one year Among those who achieved clinical ...